Child-BEAR-net

28/02/2026

Child-BEAR-net @ the 1st European Workshop on Bronchiectasis and Chronic Cough in Children and Adolescents, some details 🤩

28/02/2026

Kicking off the 1st European Workshop on Bronchiectasis and Chronic Cough in Children and Adolescents

📍Venue: Radisson Blu ChorusLife, Bergamo
🌍 Bergamo, Italy
📅 26-27 February 2026

28/02/2026

Kicking off the 1st European Workshop on Bronchiectasis and Chronic Cough in Children and Adolescents

📍Venue: Radisson Blu ChorusLife, Bergamo
🌍 Bergamo, Italy
📅 26-27 February 2026

26/02/2026

1st European Workshop on Bronchiectasis and Chronic Cough in Children and Adolescents has started today in Bergamo. Faculty dinner was lovely and delicious, thanks for arranging this excellent event

26/02/2026

Children-BEAR-Net keeps working on producing scientific recommendations to support the treatment of children with bronchiectasis and their families.

21/08/2025

This review emphasises the importance of child good respiratory health and the need for interventions to reduce or manage disease burden, which require a whole-of-society approach across the life course.
https://bit.ly/447uO9h

12/07/2025

The World Bronchiectasis Conference 2025 is just around the corner!

📍Venues: the Advanced Engineering Building (AEB) at the University of Queensland and the Brisbane Convention & Exhibition Centre (BCEC)
🌍 Brisbane, Australia
📅 14-17 July 2025

17/06/2025

And the comment here 👆🏻The power of paediatric bronchiectasis health registries (Catherine A Byrnes)
Check it out @ The Lancet Respiratory Medicine

17/06/2025

Our latest paper is out!! “First results from the international paediatric bronchiectasis registry (Child-BEAR-Net Registry) describing multicountry variations in childhood bronchiectasis and its management: a multicentre, cross-sectional study”
Check it out @ The Lancet Respiratory Medicine

10/06/2025

MARK ON YOUR AGENDAS!!!!

07/05/2025

Deemed by the European Respiratory Society as one of the most neglected lung diseases in clinical practice, Professor Marchant said the condition was relatively under-researched with large unmet needs.
“There are no current therapies, other than antibiotics, for children with bronchiectasis,” she said.
“Our study will examine whether colchicine – an old, safe, inexpensive drug – used as an adjunct anti-inflammatory, immunomodulatory therapy can improve clinical outcomes of children with bronchiectasis respiratory exacerbations.”
The QUT research team comprises chief investigators Professor Marchant, Professor Anne Chang AM, Professor Stephanie Yerkovich, Dr Vikas Goyal and Dr Hannah O’Farrell, all from the School of Medicine and AusHSI, and associate investigator Professor Steven McPhail, from the School of Public Health and Social Work and AusHSI.
Other chief investigators include Professor Keith Grimwood (Griffith University), Professor Hiran Selvadurai (Children’s Hospital at Westmead), Professor Andre Schultz (University of Western Australia), Mrs Lesley Versteegh (Menzies School of Health Research), Associate Professor Katherine Baines (The University of Newcastle), Associate Professor Anna Nathan (University of Malaya), Professor Peter Morris (Menzies School of Health Research). Dr Pamela Laird (University of Western Australia) is also an associate investigator.
Partner organisations include Children’s Hospital at Westmead, Royal Darwin Hospital, Queensland Children’s Hospital, Perth Children’s Hospital and Pharmacor.

23/02/2025